MedCap AB (publ) operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MedCap AB (publ) with three other
companies in this sector in Sweden:
Melker Schorling Ab
sales of 588.00 million Swedish Kronor [US$66.71 million]
(762.70 million Swedish Kronor [US$86.54 million]
of which 100%
was Investment Activities), and
Bure Equity AB
(460.40 million Swedish Kronor [US$52.24 million]
MedCap AB (publ) reported sales of SEK 816.92 million (US$92.69 million)
April of 2016.
decrease of 4.2%
versus 2015, when the company's sales were SEK 852.75 million.
Contributing to the drop in overall sales was the 8.6% decline
in Unimedic, from SEK 664.76 million to SEK 607.55 million.
However, these declines were partially offset by the increase in sales of
Abilia (up 3.1% to SEK 182.63 million)
Quickels (up 61.3% to SEK 17.55 million)